ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

VRX Bausch Health Cos

23.40
0.00 (0.00%)
After Hours
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Bausch Health Cos NYSE:VRX NYSE Ordinary Share
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 23.40 0.00 01:00:00

Bausch Health Companies Inc. Will Release Second-Quarter 2019 Financial Results On August 6

08/07/2019 1:00pm

PR Newswire (Canada)


Valeant Pharma (NYSE:VRX)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Valeant Pharma Charts.

LAVAL, Quebec, July 8, 2019 /CNW/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") will release its second-quarter 2019 financial results on Tuesday, Aug. 6, 2019. Bausch Health will host a conference call and live web cast at 8:00 a.m. EDT to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.

Conference Call Details

Date:

Tuesday, Aug. 6, 2019

Time:

8:00 a.m. EDT

Webcast:

http://ir.bauschhealth.com/events-and-presentations

Participant Event Dial-in: 

+1 (888) 317-6003 (United States)


+1 (412) 317-6061 (International)

+1 (866) 284-3684 (Canada)

Participant Passcode:

2275809



Replay Dial-in:

+1 (877) 344-7529 (United States)


+1 (412) 317-0088 (International)

+1 (855) 669-9658 (Canada)

Replay Passcode:

10132759 (replay available until Aug. 13, 2019)

About Bausch Health

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. More information can be found at www.bauschhealth.com.

Investor/Media Contact:
Arthur Shannon 
arthur.shannon@bauschhealth.com 
(514) 856-3855  
(877) 281-6642 (toll free)                                                                                             

Bausch Health logo (PRNewsfoto/Bausch Health Companies Inc.)

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/bausch-health-companies-inc-will-release-second-quarter-2019-financial-results-on-august-6-300878798.html

SOURCE Bausch Health Companies Inc.

Copyright 2019 Canada NewsWire

1 Year Valeant Pharma Chart

1 Year Valeant Pharma Chart

1 Month Valeant Pharma Chart

1 Month Valeant Pharma Chart

Your Recent History

Delayed Upgrade Clock